INTRODUCTION
In response to cues such as low cellular energy, eukaryotic cells initiate the degradative process of macroautophagy (hereafter referred to as autophagy) (McEwan and Dikic, 2011; Mizushima and Levine, 2010; Nakatogawa et al., 2009; Yang and Klionsky, 2009; Yorimitsu and Klionsky, 2005) . During autophagy, a double-membrane vesicle, termed autophagosome, engulfs part of the cytoplasm and fuses with a lysosome or vacuole, and its cytosolic contents are ultimately degraded and recycled. At least 18 distinct so-called ''Atg'' proteins are key core components for autophagosomal membrane formation (Nakatogawa et al., 2009; Suzuki et al., 2001) . These include the ubiquitin-like protein (UBL) Atg8 in yeast, which has six orthologs in mammals, including LC3 (Ichimura et al., 2000; Schulman and Harper, 2009) . Atg8 is unique among UBLs in being ligated to a lipid, phosphatidylethanolamine (PE) (Ichimura et al., 2000 (Ichimura et al., , 2004 . Atg8PE (where indicates a covalent bond) adducts are incorporated into the growing autophagosomal membrane (Nakatogawa et al., 2007) .
As with other UBLs, Atg8 becomes ligated via a multistep process (Geng and Klionsky, 2008; Nakatogawa et al., 2009) . First, the E1 enzyme Atg7 binds MgATP and Atg8 and catalyzes adenylation of Atg8's C terminus. Next, the resulting Atg8-acyl adenylate is attacked by Atg7's catalytic cysteine to generate a thioester-bonded Atg7Atg8 intermediate. A transthiolation reaction occurs whereby Atg8's C terminus is transferred from Atg7's catalytic cysteine to that of the E2 enzyme, Atg3, generating a thioester-linked Atg3Atg8 conjugate. Finally, Atg8 is transferred from Atg3's catalytic cysteine to PE in a reaction stimulated by an unusual multiprotein E3 containing the Atg12Atg5 complex Ichimura et al., 2000) . This is partly composed of Atg12, another UBL involved in autophagy. Like Atg8, Atg12 is activated by Atg7, although Atg12 has its own E2 (Atg10) and target (Atg5) (Mizushima et al., 1998) .
Models for the initial steps of Atg8 activation may be extrapolated from (1) structural similarity of Atg8 to canonical UBLs such as ubiquitin, NEDD8, and SUMO and bacterial antecedents MoaD and ThiS (Noda et al., 2009; Sugawara et al., 2004) and (2) sequence homology between roughly half of Atg7 to the adenylation domain found in canonical E1s and homodimeric bacterial E1 antecedents MoeB and ThiF (Mizushima et al., 1998; Noda et al., 2009; Streich and Haas, 2010; Schulman and Harper, 2009 ). However, detailed mechanisms of Atg8 conjugation for the steps following the initial adenylation reaction cannot be extrapolated from knowledge of canonical UBL pathways due to numerous fundamental differences. First, as in ThiF, Atg7's catalytic cysteine resides in a loop (Duda et al., 2005; Lehmann et al., 2006) . By contrast, in canonical E1s such as for ubiquitin, NEDD8, and SUMO, the catalytic cysteine is in a distinct domain, which undergoes a remarkable conformational change involving structural remodeling and moving close to the adenylationactive site for covalent linkage to the UBL C terminus (Olsen et al., 2010) . Another difference is that Atg7 is a homodimer, with two potential adenylation and thioester active sites per Atg7 homodimer (Komatsu et al., 2001) . By contrast, canonical E1s are pseudosymmetric and share the same MoeB/ThiF-like adenylation domain fold, but contain only a single adenylation active site, a single catalytic cysteine, and a single E2-binding site, all within the same subunit (reviewed in Schulman and Harper, 2009 ). Furthermore, Atg7-Atg3 interactions differ from canonical E1-E2 interactions: Atg7 binds a unique Atg3 ''flexible region'' (referred to hereafter as Atg3 FR ) not found in canonical E2s (Yamada et al., 2007) . The Atg3 FR has many acidic residues (theoretical pI of yeast Atg3 FR = 3.54) interspersed with some hydrophobic residues and is disordered in solution (Yamada et al., 2007) . Atg7 also has unique features, most notably an 300-residue N-terminal region that lacks any known function or sequence homology to any other proteins. In this study, we identify Atg7's N-terminal domain (Atg7 NTD ) as the binding site for the Atg3 FR . We find that Atg7 utilizes a unique mechanism that relies on its homodimerization to mediate E1-to-E2 UBL transfer in trans. Biophysical, X-ray crystallographic, and biochemical experiments reveal the structural basis and functional importance of distinctive E1-E2 interactions required for optimal Atg8 conjugation in the autophagy pathway.
RESULTS

Dimerization and Structure of Atg7
CTD : Overall Similarity to MoeB, ThiF, and Canonical E1s To gain insight into the overall architecture of Atg7, we mapped two structural domains in the yeast protein ( Figure 1A ) based on prior studies (Ichimura et al., 2000; Komatsu et al., 2001) , sequence analysis, and deletion mutants (data not shown). The Atg7 NTD spans residues 1-289 and does not display sequence homology to indicate structure or function. The Atg7 C-terminal domain (Atg7 CTD ) sequence has three regions. First, residues 294-473 and 512-572 are homologous to the adenylation domains of canonical E1s for ubiquitin, NEDD8, and SUMO as well as to the bacterial enzymes MoeB and ThiF, which catalyze C-terminal acyl-adenylation of MoaD and ThiS, respectively; both MoaD and ThiS have a UBL fold (Lake et al., 2001; Lehmann et al., 2006) . Second, residues 474-511 contain the catalytic Cys507 and correspond to a ''cysteine loop'' or ''crossover loop'' crossing over the adenylation domain in MoeB/ThiF-like enzymes. Finally, Atg7's 60 extreme C-terminal residues lack homology to other E1s, but are required for expression in E. coli (data not shown) and presumably folding, and for homooligomerization and UBL-binding in yeast (Komatsu et al., 2001) . A short linker connects the Atg7 NTD and Atg7 CTD .
Previous studies indicated that Atg7 forms a homodimer in vivo (Komatsu et al., 2001) . To understand the roles of our identified domains in assembly of exogenously expressed Atg7, we performed analytical ultracentrifugation experiments on full-length 
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NTD , and Atg7 CTD . The experimental molecular weights reveal that Atg7 and Atg7 CTD are dimeric in solution, whereas the Atg7 NTD is monomeric ( Figure 1B ). Sedimentation equilibrium data indicate high-affinity dimer equilibrium dissociation constants for full-length Atg7 and Atg7 CTD of 1 nM and 30 nM, respectively ( Figure 1B) Figure S1 ). Consistent with sequence analysis, the Atg7 CTD structure also has some distinctive features. The first helix is less kinked and extended, perhaps for stability for connection to the Atg7 NTD .
Second, the cysteine loop is slightly longer than that in MoeB/ Figure 1A , and the other in gray.
(B) Structural comparison of Atg7 CTD adenylation domain with those of MoeB, ThiF, and E1s for ubiquitin (UBA1), NEDD8 (NAE1-UBA3), and SUMO (SAE1-UBA2), depicted without cysteine loops/domains for clarity, with cognate UBLs in corresponding colors below (Huang et al., 2007; Lake et al., 2001; Lee and Schindelin, 2008; Lehmann et al., 2006; Lois and Lima, 2005; Noda et al., 2008) . UBA1 (ubiquitin E1) is one polypeptide, but represented according to N-and C-terminal halves. Atg8's C-terminal tail is missing in the structure and is therefore depicted as a dashed line. PDB codes are shown below each structure. ThiF and, in our structure, packs against the adenylation domain. The crystallized conformation of the cysteine loop would block access of Atg8's C-terminal tail to the adenylation and cysteine active sites. Furthermore, although the Ca of the catalytic Cys507 is only 8 Å from both a modeled Atg8 C terminus and ATP a-phosphate, the cysteine side chain faces the opposite direction from that necessary for forming an Atg7Atg8 intermediate. Thus, despite its proximity to the adenylation active site, the cysteine loop must adopt different conformations during catalysis. Consistent with conformational flexibility, the cysteine loop is only partially ordered and has high B factors in our structure. Notably, the corresponding regions of MoeB, ThiF, and E1s also fluctuate upon UBL binding and/or formation of an E1UBL thioester intermediate (Duda et al., 2005; Lake et al., 2001; Lehmann et al., 2006; Lois and Lima, 2005; Olsen et al., 2010; Walden et al., 2003) . Finally, although the 16 C-terminal amino acids are not visible in the structure, residues 573-614 form a four-helix platform extreme C-terminal domain (ECTD) that makes extensive hydrophobic interactions with the remainder of the CTD, explaining their requirement for Atg7 folding. The most C-terminally observed residue is poised near Atg8 modeled based on other E1-UBL structures. Future studies will be required to understand detailed functions of the extreme C-terminal portion of Atg7.
Atg7 N-Terminal Domain Recruits the Atg3 ''Flexible Region'' We next mapped high-affinity binding between Atg7 and Atg3, which interact with a K d of 0.35 mM as measured by isothermal titration calorimetry (ITC) (Figure 3 ). Atg7
NTD retains much affinity for Atg3, with a K d of 1.85 mM ( Figure 3C ). A previous study showed that Atg3 FR (residues 84-162) binds Atg7, and an Atg3
Molecular Cell Atg7-Atg3: A Unique E1-E2 Mechanism in Autophagy mutant lacking the FR region was defective for autophagy (Yamada et al., 2007) . Indeed, we found that deleting the FR region (residues 86-159, hereafter referred to as Atg3 DFR ) reduces the K d for full-length Atg7 by more than 40-fold and eliminates binding to the Atg7 NTD under our assay conditions ( Figure 3C ).
To identify the region within the >80-residue Atg3 FR essential for binding Atg7 NTD , we examined co-pull-downs of His 6 -MBPtagged Atg3
FR deletion mutants and GST-tagged Atg7 NTD upon their coexpression in E. coli. Atg3 residues 130-142 appear to be both necessary and sufficient for binding to Atg7 NTD in this assay ( Figure S2 ). Furthermore, a synthetic peptide encompassing Atg3 residues 128-144 (Atg3 FRpep ) binds similarly to both full-length Atg7 and Atg7 NTD , with 5.9 and 6.3 mM K d values, respectively (Figures 3B and 3C) .
To understand details of Atg7-Atg3 interactions, we determined, using yeast proteins, crystal structures of Atg7
NTD by single-wavelength anomalous diffraction using selenomethionine-substituted protein and of an Atg7 NTD -Atg3 FRpep complex by molecular replacement using the Atg7 NTD structure as a search model (Figures S2, S3, and 4A; Table 1 ). The Atg7 NTD fold is comprised of two structurally similar subdomains, each with a 5-stranded mixed b sheet sandwiched between two a helices, with distinct flanking helices and loops ( Figure S3 ). The subdomains are interconnected by three extended loops spanning the entire length of the Atg7 NTD such that the N and C termini are at opposite ends ( Figure S3 ). A hydrophobic groove in Atg7, which has b strands 5, 6, and 15 as its floor and a helix 3 and the b14/b15 loop as its sides, cradles the Atg3
FRpep . In complex with Atg7 NTD , the Atg3
FRpep adopts a two-turn helix followed by a short extension ( Figure 4A ). Interestingly, NMR data previously indicated that in the absence of Atg7, the Atg3 FR adopts a disordered structure both on its own 
Resolution ( and in the context of full-length Atg3 (Yamada et al., 2007) . Furthermore, it seems that the residues corresponding to the Atg3 FRpep can adopt a range of conformations, because the corresponding sequence is the only portion of the FR visible in a prior crystal structure of full-length Atg3 (PDB code: 2DYT), where the Atg3
FRpep sequence forms a helix (Yamada et al., 2007) . Consistent with its structural flexibility, in the crystal structure of full-length Atg3, this region has substantially higher B factors than the rest of Atg3 (91 versus 51), half the side chains including that of Met139 are not observed, and lack of the majority of the FR raises the possibility that the observed Atg3
FRpep sequence comes from an adjacent Atg3 in the crystal to mediate packing ( Figure S2 ). It seems likely that the structural malleability of the Atg3 FRpep region facilitates accessibility of this region for binding to Atg7. The Atg7-Atg3 FRpep interaction is mediated by hydrophobic side chains from Atg3 inserting into the Atg7 hydrophobic groove ( Figure 4B ). The interface is centered around Atg3 residue Met139 docking in a hydrophobic pocket formed by Atg7 residues Phe93, Lys94, Trp139, and Pro283. This is buttressed on one side by Atg3 residue Leu135 making hydrophobic contacts with Atg7 residues Leu90, Phe93, Lys94, and Tyr137. On the other side, Atg3 residue Ile141 interacts with Atg7 residues Lys98, Trp139, Trp273, and Leu281. Overall, the interaction buries 940 Å 2 of surface area.
Notably, the Atg3 FRpep -binding groove in Atg7 is continuous through to the junction of the two subdomains, where this portion of Atg7 NTD is strikingly basic in character. On this basis, we can approximate the trajectory for more of Atg3's FR: the ten residues following the structurally observed sequence are almost entirely acidic and likely traverse through the basic cleft in the Atg7 NTD ( Figure S3 ).
Role for Atg7 NTD -Atg3
FRpep Interface in Atg7-Atg3
Interactions and Atg8 Transfer We investigated whether the structurally observed interface is important for the Atg7 NTD -Atg3 interaction by pull-down after bacterial coexpression of several versions of GST-Atg7 NTD and
His 6 -MBP-Atg3. Because nonbulky hydrophobic residues mediate the interaction, we tested effects of pairs of hydrophobic-to-alanine mutations in Atg3. From Atg7, we made single hydrophobic-to-aspartic acid mutations to diminish the overall hydrophobic character of the groove. Pulling down on the His 6 -MBP tag shows that wild-type Atg3 is able to copurify similar amounts of wild-type Atg7 NTD . Pairwise alanine mutations in Atg3 Leu135, Met139, and Ile141 or individual aspartic acid substitutions in place of Atg7 NTD Tyr137, Trp139, or Pro283 diminished the interaction ( Figure 4C ). In the reciprocal pulldown for GST-Atg7 NTD , even for the wild-type proteins, only a substoichiometric amount of His 6 -MBP-Atg3 copurifies, as would be the case if GST-Atg7 NTD were present in significant excess during the coexpression. Nonetheless, reduced interaction is observed for all the mutants, which are expressed at wildtype levels ( Figure 4C ). We next tested whether the structurally observed Atg7 NTD -
Atg3
FRpep interaction plays a role in Atg8 transfer from Atg7 to Atg3 using a pulse-chase assay. Briefly, in the ''pulse'' reaction, we incubated Atg7 Figure 4D ). In agreement with the structure, mutations at the Atg7 NTD -Atg3 FRpep interface cripple transfer of [ 32 P]Atg8 from Atg7 to Atg3 ( Figure 4D ). This effect is mirrored in an in vitro 
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Atg7-Atg3: A Unique E1-E2 Mechanism in Autophagy reaction reconstituting the Atg8 pathway: in the presence of MgATP, Atg3, an Atg12Atg5 E3, and PE-containing liposomes, Atg8 lipidation is impaired in reactions containing the Pro283Asp mutant version of Atg7 ( Figure 4E ). Furthermore, an important role for the hydrophobic Atg7-Atg3 interactions may be inferred from our finding that salt has little effect on Atg8 transfer from Atg7 to Atg3 ( Figure S3 ). To provide support for the notion that the deleterious effects of Atg7 NTD mutations arose from eliminating the interaction with Atg3 FR and not from global misfolding, we determined the crystal structure of the most impaired mutant. Despite subtle differences in crystal packing, the Pro283Asp mutant structure superimposes with wild-type Atg7 NTD with 0.55 Å rmsd, confirming correct folding ( Figures S2 and S3 ). Figure 5B ). To test function in vivo, we stably expressed an N-terminally GFP-tagged mouse Atg7, the Pro310Asp mutant, or the catalytic Cys567Ala mutant in Atg7 null MEF cell lines. Chloroquine was added to induce accumulation of autophagosomes. Notably, accumulation of LC3-II was impaired by the mutation in the Atg3 FRpep binding site ( Figure 5C ). The deleterious effects of the mutation are specific for the Atg3 pathway, because no effect is observed for ligation of Atg12 to Atg5 ( Figure 5C ), which is mediated by a different E2, Atg10, that is homologous to part of Atg3 but lacks an obvious FR sequence.
Model for Transfer of Atg8 from Atg7 onto Atg3: A Unique trans Mechanism
We made a structural model to obtain insights into the role of Atg7 NTD -Atg3 FRpep interactions in the context of full-length Atg7 and Atg3. First, to understand relative positioning of Atg7's N-and C-terminal domains, we examined small-angle x-ray scattering (SAXS) of Atg7 ( Figures 6A and S4) . It is not possible based on the data to definitively orient the two domains relative to each other, although a model fitting the homodimeric Atg7 CTD and two Atg7 NTD s generated with the program BILBOMD (Pelikan et al., 2009 ) yielded a reasonable fit (c 2 = 1.5) ( Figure 6A ). Overall, the best-fitting model is consistent with the two Atg7 NTD s extending away from a central Atg7 CTD homodimeric structure in solution ( Figure S4 ). Next, to determine Atg7:Atg3 stoichiometry upon juxtaposition of their catalytic cysteines, we performed size-exclusion chromatography-multiangle light scattering (SEC-MALS) on a crosslinked sample. To attach a crosslinker specifically to the Atg3 active site, we made a mutant in which the only cysteine is the catalytic Cys234 (Atg3C234only). After reacting Atg3C234only with bis-maleimidoethane (BMOE, a short-spacer homobifunctional sulfhydryl crosslinker) and desalting to remove any excess unreacted BMOE, Atg3C234onlyBMOE becomes crosslinked to wild-type Atg7, but not a catalytic Cys507Ala mutant, indicating crosslinking between the Atg7 and Atg3 active-site cysteines. The SEC-MALS-determined molecular weight of the Atg7BMOEAtg3C234only crosslinked complex closely matches that of a 2:2 dimer (211 kDa versus 215 kDa expected) ( Figure 6B) .
Thus, to generate a structural model, we placed the Atg7 and Atg3 catalytic cysteines near each other and modeled in the Atg7 NTD -Atg3 FRpep , consistent with relative locations of the Atg7 CTD and Atg7 NTD from SAXS data, while maintaining reasonable distances for connections to the remainder of Atg3. The model suggests a mechanism of E1-E2 transthiolation that differs from canonical E1s and E2s such as for ubiquitin, NEDD8, and SUMO, for which the same E1 subunit contains both the catalytic cysteine and E2-binding regions for UBL transfer in cis (Schulman and Harper, 2009 ). Instead, a distinctive ''trans'' mechanism provides a rationale for Atg7 homodimerization: Atg8 linked to the catalytic cysteine of one Atg7 CTD would be transferred to Atg3 associated with the Atg7 NTD of the opposite Atg7 protomer in the dimer (Figures 6C and S4) . To test the model, we coexpressed His 6 -and GST-tagged Atg7 in E. coli and sequentially performed affinity capture with Ni 2+ agarose beads and then with glutathione Sepharose beads to obtain Atg7 dimers containing two different protomers. Using this method, we made two mutant Atg7s. Atg7 trans contains two mutant versions of Atg7 that together form a dimer: one mutant has an alanine substitution in place of the catalytic Cys507, and the other has the Pro283Asp mutation that hinders the Atg7 NTD from binding Atg3. Our sequential affinity capture purification yields a mixed dimer where one protomer is unable to form a thioester with Atg8, but retains Atg3 FR binding, and the other protomer is able to form a thioester linkage with Atg8, but is defective in recruiting the Atg3 FR ( Figure 6D ). Therefore, the only way for Atg7 trans to mediate Atg8 transfer would be if Atg3 binds one Atg7 NTD and accepts Atg8 from the catalytic cysteine of the opposite Atg7 in the dimer. By contrast, the Atg7 cis dimer contains one wild-type Atg7 and one double Cys507Ala/ Pro283Asp mutant that would be defective in both forming a thioester with Atg8 and binding to Atg3 ( Figure 6D ). Thus, Atg7 cis would only be active if Atg8 were transferred between the Atg7 catalytic cysteine and an Atg3 associated with the Atg7 NTD of the same protomer of Atg7. Using our pulse-chase assay, we find that Atg7 preferentially carries out transthiolation in trans ( Figure 6E ). In order to test whether the Atg7 NTD -Atg3 FRpep interaction helps position the Atg3 active site near that of Atg7 as in our model, we again turned to crosslinking, adding Atg3C234only BMOE to either wild-type Atg7, Atg7 with its catalytic Cys507 mutated to alanine, Atg7 Pro283Asp, Atg7 trans , or Atg7 cis . We observe complete disappearance of wild-type Atg7 and concomitant appearance of a single higher-molecular-weight band corresponding to Atg7 crosslinked to Atg3 ( Figure 6F ). This band does not form with the Atg7 Cys507Ala mutant, in agreement with the notion that BMOE is crosslinking the Atg7
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Atg7-Atg3: A Unique E1-E2 Mechanism in Autophagy and Atg3 catalytic cysteines ( Figure 6F ). Complete crosslinking of wild-type Atg7 is consistent with the Atg7 homodimer binding concurrently to two molecules of Atg3. Significantly less crosslinked product forms with the Pro283Asp mutant ( Figure 6F ), supporting the view that the structurally observed interaction helps position Atg3's catalytic cysteine in proximity to that of Atg7. Similar low-level formation of the crosslinked product is observed for Atg7 cis , in which one member of each dimer contains both the Cys507Ala and Pro283Asp mutations. Notably, substantially more crosslinked product is formed with Atg7 trans , in which one protomer within the dimer contains the Cys507Ala mutation while the other contains the Pro283Asp mutation ( Figure 6F) . Crosslinking of the trans complex is also more efficient than the cis complex when 2-fold higher molar concentrations of Atg7 cis and Atg7 trans are used relative to wild-type Atg7, such that the concentrations of Atg7 catalytic cysteines available to form the crosslink are identical in all cases (two catalytic cysteines per wild-type Atg7 homodimer, but only one catalytic cysteine per Atg7 cis or Atg7 trans dimer) ( Figure 6F ).
Thus, the crosslinking results agree with our structural model and support an overall ''trans'' architecture for the Atg7-Atg3 complex. We wondered whether the flexibility and relative placement of the Atg7 NTD , which binds the Atg3 FR , and the Atg7 CTD , whose catalytic cysteine is thioester linked to Atg8, influences Atg8 transfer between Atg7 and Atg3. Thus, we made mutations probing flexibility between the domains: a glycine mutation in place of the conserved Pro294 was designed to test effects of increasing flexibility while maintaining linker length, and a mutant with the sequence Gly-Gly-Ser-Gly inserted in between residues Ser290 and Leu291 was designed to test effects of lengthening the linker. The Pro294Gly mutant displayed wild-type ability to mediate transfer of Atg8 to Atg3, whereas the insertion mutant was severely impaired ( Figure 6G ). The results are consistent with the notion that the Atg7 NTD and Atg7 CTD may be flexibly tethered but that the distance between them is optimized for the transthiolation reaction.
DISCUSSION
Eukaryotic UBLs and E1s appear to have originated from ancient prokaryotic biosynthetic pathways. E. coli MoaD and ThiS represent prokaryotic UBLs, which function in 2:2 complexes with their respective homodimeric E1-like enzymes, MoeB and ThiF, in the biosynthesis of molybdopterin and thiamine, respectively (Hochstrasser, 2000; Schulman and Harper, 2009; Streich and Haas, 2010) . The theme represented by MoeB and ThiF has been elaborated upon over the course of evolution, giving rise to eukaryotic E1s that bind both UBLs and E2s and can be classified as either canonical or noncanonical (Hochstrasser, 2000; Schulman and Harper, 2009; Streich and Haas, 2010) . Our structural studies now show that the noncanonical Atg7, like other E1s, possesses at its core a MoeB/ThiF-like adenylation domain. E1s have a variety of additions to this scaffold. . Third, on this basis, we were able to introduce a mutation into yeast Atg7 that leads to defects in Atg3Atg8 formation in vitro and into mouse Atg7 that leads to defects in conjugation of LC3, a mammalian Atg8 ortholog, in cells. Finally, we identify a distinctive ''trans'' E1-to-E2 Atg8 transfer mechanism that provides a rationale for the homodimerization of Atg7: Atg3 bound via its FR to one Atg7 NTD accepts
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Atg8 from the catalytic cysteine of the opposite Atg7 protomer in the dimer. Prior studies on the canonical E1s reveal a trend among these enzymes: their catalytic cysteine domains and E2-binding domains undergo rotations relative to their MoeB/ThiF-like adenylation domain cores (Huang et al., 2007; Olsen et al., 2010) . Also, the domain housing a canonical E1's catalytic cysteine undergoes striking conformational remodeling during formation of an E1UBL intermediate (Olsen et al., 2010) . In this study, we find parallel characteristics in Atg7, despite its unique structural features. We observe the potential for flexibility between the Atg7 NTD and Atg7 CTD due to the presence of a linker between the two domains. Furthermore, catalysis of both Atg8 adenylation and formation of an Atg7Atg8 intermediate would require the Atg7 cysteine loop to adopt different conformations from that observed in our crystal structure of Atg7 CTD . Future studies will be necessary to understand the extent of structural remodeling that occurs in the Atg7 cysteine loop during catalysis and how orientation of Atg7 domains might confer functional roles to the enzyme. In addition to interacting with Atg3 during conjugation of the UBL Atg8, Atg7 has the additional function of activating a second UBL, Atg12, which functions via the distinct E2, Atg10. Notably, we have been able to introduce a mutation in mouse Atg7 that separates these two pathways. The Pro310Asp mutation in the mouse Atg7 NTD, made based on our crystal structure of yeast Atg7 NTD -Atg3 FR , hinders both binding to Atg3 and LC3 conjugation in cells. This had no observable effect on Atg12 conjugation in cells ( Figure 5C ). Consistent with this notion, Atg10 sequences lack an obvious FR. Taken together with our crystallographic data indicating that Atg3 FRpep binds in a groove in Atg7, the results raise the possibility that small molecule inhibitors selectively inhibiting Atg8 conjugation may be obtainable. How might Atg7 interact with its distinct E2s? We speculate that the answer to this question relates to our finding that Atg3 binds full-length Atg7 with a 6-fold greater affinity than it binds Atg7 NTD . Thus, in addition to the high-affinity Atg7 NTD -Atg3 FR interaction investigated here, it seems likely that there are additional weak contacts between the Atg7 CTD and Atg3 DFR .
We speculate that these are likely mirrored by Atg10, which displays some sequence similarity to Atg3 DFR . Moreover, in our structural model of an (Atg7Atg8-Atg3) 2 complex, Atg3 is located near Atg8, raising the possibility that the UBLs Atg8 and Atg12 help mediate specificity of transfer to their own distinct E2s, although difficulty in producing purified Atg12 precludes us from currently addressing this. We anticipate many exciting new features of E1s will be revealed from future studies of these and other interactions and mechanisms involved in E1-to-E2 UBL transfer in autophagy.
EXPERIMENTAL PROCEDURES
Details on constructs, protein expression, and protein purification are provided in the Supplemental Information.
X-Ray Crystallography
All crystals were grown in hanging drops. Crystals of selenomethioninelabeled Atg7
NTD were grown at 4 C by streak-seeding drops prepared by mixing 1 ml 20-60 mg/ml Atg7 NTD in 25 mM Tris (pH 7.6), 150 mM NaCl, and 10 mM DTT with 1 ml well solution containing 9.2% isopropanol, 0.1 M potassium thiocyanate, and 0.1 M citrate buffer (pH 4.0). Crystals were cryoprotected in well solution supplemented with 6% glycerol, 6% ethylene glycol, and 6% sucrose. Phasing via identification of the three Se sites and initial model building were performed with Phenix AutoSol (Adams et al., 2010 crystallized at 4 C in 12% PEG20k, 0.1 M Tris 8.5, 10 mM TCEP and upon harvesting were soaked in 13% PEG20k, 0.1 M Tris 8.5, 10 mM TCEP, 7.5% ethylene glycol, 7.5% glycerol prior to cryoprotection in 13% PEG20k, 0.1 M Tris 8.5, 10 mM TCEP, 15% ethylene glycol, 15% glycerol. Phases were obtained using molecular replacement/single-wavelength anomalous diffraction (MR-SAD) at the zinc peak wavelength with ThiF (Chain A, 1ZKM.pdb) (Duda et al., 2005) as the search model with Phenix (Adams et al., 2010) . All crystals were flash frozen in liquid nitrogen. Diffraction data were processed with HKL2000 (Otwinowski and Minor, 1997) . After phasing, cycles of manual model rebuilding and refinement were performed with Coot (Emsley et al., 2010) and phenix.refine (Adams et al., 2010) . In the crystal, Atg7 CTD forms a symmetric homodimer, with one Atg7 CTD monomer in the asymmetric unit and the second subunit in the homodimer generated through application of crystallographic symmetry operators.
Biophysical Analyses ITC was performed with proteins/peptides in 25 mM HEPES (pH 8.0), 150 mM NaCl, and 2 mM b-mercaptoethanol (BME) at 30 C using a MicroCal iTC200.
Atg7 and Atg7 NTD were placed in the sample cell at concentrations of 35-90 mM, with titrating Atg3, Atg3 DFR , or Atg FRpep in the syringe. Data were evaluated using Origin (V 7.0) to determine the values of the thermodynamic parameters and are shown as means ± SD (n = 3). AUC, SAXS, and SEC-MALS analyses are described in detail in the Supplemental Information.
Biochemical Analyses
Pulse-chase assay was adapted from Huang et al., 2009 . Atg8 was expressed with an N-terminal protein kinase A (PKA) tag for 32 P labeling using PKA (New England Biolabs). Atg7 proteins were charged with [ 32 P]Atg8 in reactions containing 50 mM HEPES (pH 7.5), 2 mM ATP, 5 mM MgCl 2 , 2 mg/ml BSA, 1 mM Atg7 (wild-type or mutants) and 2.5 mM [ 32 P]Atg8 (for assays in Fig- ure S3E, 5 mM ATP, 10 mM MgCl 2 , and 5 mM [ 32 P]Atg8 was used). For all assays except that in Figure S3E , charging reactions were desalted into 50 mM HEPES (pH 7.5), 50 mM EDTA (pH 8.0) to prevent reloading of Atg7. For the chase, [ 32 P]Atg8 transfer from Atg7 to Atg3 was assayed in reactions containing 100 mM HEPES (pH 7.5), 2 mg/ml BSA, 50 mM EDTA (pH 8.0), 500 nM Atg3 with a 1:5 dilution of desalted Atg7[ 32 P]Atg8 (for assays in
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Atg7-Atg3: A Unique E1-E2 Mechanism in Autophagy Figure S3E , 5 mM Atg3 was used and chase was performed on ice). Since the Atg7 trans and Atg7 cis contain half as many active/Atg3-binding sites as wild-type Atg7, twice as many of these enzymes were used relative to wildtype Atg7. Reactions were quenched with 23 SDS loading buffer and run on Nu-PAGE 4%-12% Bis-Tris gels in MOPS buffer (Invitrogen).
Crosslinking assays used mutant Atg3 in which all cysteines other than the catalytic Cys234 were mutated to alanine (Atg3C234only). Atg3C234only was reduced with 10 mM DTT then desalted in 20 mM HEPES (pH 7.0), 150 mM NaCl. Atg3C234only (100 mM) was mixed with 5-fold molar excess of BMOE (Pierce) and incubated on ice for >1 hr, followed by removal of unreacted crosslinker by desalting. Atg7 proteins were reduced with 2 mM TCEP. Crosslinking was initiated by adding Atg3C234onlyBMOE to Atg7 such that the final Atg3 concentration was 120 nM and the final Atg7 concentration was 60 or 120 nM as indicated. After 60 s, crosslinking was quenched with 100 mM DTT. Samples were separated by SDS-PAGE, transferred to PVDF membrane, and detected by immunoblotting against Atg7 (yN-16, Santa Cruz, #SC8964).
Cell-based assays, pull-downs, Atg8 lipidation, and formation of the Atg7Atg8 thioester intermediate are described in the Supplemental Information.
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